中国东北地区黑色素瘤临床病理特征与预后:229例区域队列研究
该研究收集吉林大学第一医院229例连续非选择性黑色素瘤患者的人口学、临床病理及治疗数据,分析发病与临床病理特征。中位总生存53.5个月,1年、3年、5年生存率分别为86.3%、66.4%、44.8%;多因素分析显示疾病分期、ECOG评分和乳酸脱氢酶是总生存的独立预后因素,病理亚型和分期是无病生存的独立预后因素。
要点
- 中位总生存53.5个月,5年生存率44.8%;中位无病生存33.1个月,5年无病生存率35.8%。
- 疾病分期、ECOG评分和乳酸脱氢酶是总生存的独立预后因素。
- 病理亚型和分期是无病生存的独立预后因素;血管侵犯在肢端黑色素瘤中与总生存相关。
核心结论
- 血管侵犯可能是肢端和皮肤黑色素瘤患者的预后因素。
- 中国东北人群与高加索人群在疾病部位、病理亚型、基因状态和生存预后方面存在显著差异。
研究设计与样本
- 区域队列研究,收集吉林大学第一医院(中国长春)治疗的黑色素瘤患者人口学、临床病理和治疗数据。
- 共分析229例连续非选择性病例的发病率和临床病理特征。
主要发现
- 中位总生存53.5个月,1年、3年、5年生存率分别为86.3%、66.4%、44.8%。
- 中位无病生存33.1个月,1年、3年、5年无病生存率分别为75.0%、48.5%、35.8%。
- 多因素分析显示疾病分期、ECOG评分和乳酸脱氢酶是总生存的独立预后因素。
- 病理亚型和分期是无病生存的独立预后因素。
- 血管侵犯是肢端黑色素瘤总生存的预后因素,也是皮肤黑色素瘤无病生存的预后因素。
临床怎么用
- 在肢端和皮肤黑色素瘤患者中可关注血管侵犯作为预后评估指标。
- 疾病分期、ECOG评分和乳酸脱氢酶可用于总生存的预后评估。
- 病理亚型和分期可用于无病生存的预后评估。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Melanoma has been reported in many parts of East Asia. However, there are no reports on the epidemiology of melanoma in Northeast China. In this study, we collected demographic, clinicopathologic, and treatment data of patients with melanoma treated at the First Hospital of Jilin University (Changchun, China). A total of 229 consecutive nonselective cases were analyzed for the incidence and clinicopathologic characteristics of melanoma. The median overall survival was 53.5 months. The 1-year, 3-year, and 5-year survival rates were 86.3, 66.4, and 44.8%, respectively. The median disease-free survival was 33.1 months, and the 1-year, 3-year, and 5-year disease-free survival rates were 75.0, 48.5, and 35.8%, respectively. Multivariate analysis showed that disease stage, Eastern Cooperative Oncology Group score, and lactic dehydrogenase were independent prognostic factors of overall survival. Pathologic subtype and stage were independent prognostic factors of disease-free survival. Furthermore, vascular invasion was a prognostic factor for overall survival in acral melanoma and a prognostic factor for disease-free survival in cutaneous melanoma. Compared with the Caucasian population, the population of Northeast China showed significant differences in disease location, pathologic subtype, gene status, and survival prognosis. In summary, our study showed that vascular invasion might be a prognostic factor in patients with acral and cutaneous melanoma.
引用
- Guo Z, Liu Q, Lan S, et al. Clinicopathologic Features and Prognosis of Melanoma in Northeast China: A Region-Based Cohort Study of 229 Consecutive Cases. J Invest Dermatol. 2023. PMID: 37207808. doi:10.1016/j.jid.2023.04.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。